7 mins read

Hospital Financial Decisions Play a Role in the Critical Shortage of Pediatric Beds for RSV Patients

The dire shortage of pediatric hospital beds plaguing the nation this fall is a byproduct of financial decisions made by hospitals over the past decade, as they shuttered children’s wards, which often operate in the red, and expanded the number of beds available for more profitable endeavors like joint replacements and cancer care. To cope […]

15 mins read

Empresas de capital riesgo invierten en el negocio de los ensayos clínicos de medicamentos. ¿Cuál es el riesgo para los pacientes?

Tras haber tenido éxito invirtiendo en las áreas más lucrativas de la medicina, como los centros quirúrgicos y las consultas de dermatología, las empresas de capital riesgo/inversión se han adentrado agresivamente en los nichos más ocultos del sector. Están invirtiendo miles de millones en el negocio de los ensayos clínicos de medicamentos. Para lanzar un […]

13 mins read

The Business of Clinical Trials Is Booming. Private Equity Has Taken Notice.

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry’s more hidden niches: They are pouring billions into the business of clinical drug trials. To bring a new drug to market, the FDA requires pharmaceutical […]

1 min read

Watch: The Politics of Health Care in California

KHN senior correspondent Angela Hart joined the nonpartisan group Democracy Winters on Nov. 19 to discuss the politics of health care in California. She focused on Gov. Gavin Newsom’s major health care initiatives, including a transformation of the state Medicaid program that will bring nontraditional, social services to some enrollees — with a focus on […]